Calibre Scientific Acquires NeXtal Biotechnologies to Further Expand its Protein Portfolio
Qiagen N.V. Common Shares (QGEN)
Last qiagen n.v. common shares earnings: 2/4 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
corporate.qiagen.com/investor-relations
Company Research
Source: GlobeNewswire
LOS ANGELES, Jan. 08, 2020 (GLOBE NEWSWIRE) -- Calibre Scientific is pleased to announce that it has completed the acquisition of the NeXtal Biotechnologies line of structural biology products from Qiagen NV (NYSE: QGEN). NeXtal specializes in the production of unique screens and plates for protein crystallization, an important step in the complex process of structural biology studies and structure-based drug design. NeXtal’s products include a comprehensive suite of reliable crystallization screens and proprietary EasyXtal crystallization plates that are currently sold into academic, biotechnology, and pharmaceutical markets. “This acquisition is an exciting addition to our existing structural biology solutions,” said Ritesh Mittal, General Manager of Anatrace. “NeXtal’s line of crystallization products align with our existing offerings in this space, which include Anatrace, Microlytic, and Molecular Dimensions products. NeXtal’s focus on simplifying and accelerating the protein
Show less
Read more
Impact Snapshot
Event Time:
QGEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
QGEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
QGEN alerts
High impacting Qiagen N.V. Common Shares news events
Weekly update
A roundup of the hottest topics
QGEN
News
- QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inherited disease applications [Yahoo! Finance]Yahoo! Finance
- QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inherited disease applicationsGlobeNewswire
- Qiagen N.V. (NYSE:QGEN) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Qiagen (NYSE: QGEN) had its price target lowered by analysts at Stifel Nicolaus from $55.00 to $45.00. They now have a "hold" rating on the stock.MarketBeat
- Qiagen First Quarter 2024 Earnings: EPS Beats Expectations [Yahoo! Finance]Yahoo! Finance
QGEN
Earnings
- 4/29/24 - Beat
QGEN
Sec Filings
- 5/1/24 - Form 6-K
- 5/1/24 - Form 6-K
- 3/11/24 - Form 20-F
- QGEN's page on the SEC website